Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Testing a Claim about Population Proportion01:24

Testing a Claim about Population Proportion

A complete procedure for testing a claim about a population proportion is provided here.
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Receiver Operating Characteristic Plot01:15

Receiver Operating Characteristic Plot

A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Magnetic resonance fingerprinting of the bladder is feasible in men with lower urinary tract symptoms.

Abdominal radiology (New York)·2026
Same author

Transperineal 3D vector magnetic resonance elastography of the prostate is feasible in men with benign prostatic hyperplasia and lower urinary tract symptoms.

Abdominal radiology (New York)·2026
Same author

Combining Serum Prostate Health Index With Urinary PCA3 and TMPRSS2:ERG RNA Testing Improves Detection of Clinically Significant Prostate Cancer.

JU open plus·2026
Same author

Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratification.

Blood cancer journal·2025
Same author

Clinical feasibility of MRI-guided in-bore prostate biopsies at 0.55T.

Abdominal radiology (New York)·2025
Same author

Comprehensive whole-genome sequence analyses provide insights into the genomic architecture of cerebral palsy.

Nature genetics·2024

Related Experiment Video

Updated: May 28, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Borrowing Information across Populations in Estimating Positive and Negative Predictive Values.

Ying Huang1, Youyi Fong, John Wei

  • 1Fred Hutchinson Cancer Research Center, Vaccine & Infectious Disease / Public Health Sciences, 1100 Fairview Avenue N., Seattle, WA 98109, USA.

Journal of the Royal Statistical Society. Series C, Applied Statistics
|October 25, 2011
PubMed
Summary

This study introduces a method to improve disease risk prediction by combining data from different populations. This approach enhances the accuracy of positive predictive value (PPV) and negative predictive value (NPV) estimates for markers like PCA3 in prostate cancer.

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Related Experiment Videos

Last Updated: May 28, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

  • Biostatistics
  • Epidemiology
  • Medical Diagnostics

Background:

  • Disease risk prediction marker performance relies on disease prevalence and classification accuracy.
  • Classification accuracy is often considered an intrinsic marker property, independent of disease prevalence.
  • Estimating population-specific predictive values (PPV, NPV) is crucial for clinical application.

Purpose of the Study:

  • To evaluate population-specific performance of risk prediction markers (PPV, NPV) using data from multiple populations.
  • To develop statistical methods for optimally combining information across populations to improve estimation efficiency.
  • To assess the utility of PCA3 as a risk marker for prostate cancer.

Main Methods:

  • Developed estimators that optimally combine information from the target population and another population.
  • Leveraged receiver operating characteristics (ROC) curve properties to assess marker classification accuracy across populations.
  • Applied the methodology to a cross-sectional study evaluating PCA3 for prostate cancer risk.

Main Results:

  • Borrowing information across populations can increase efficiency in estimating PPV and NPV when marker classification accuracy is similar.
  • The developed estimators provide a statistically optimal way to combine cross-population data.
  • PCA3 was evaluated as a risk prediction marker in subjects with and without prior negative biopsies.

Conclusions:

  • Combining data across populations can enhance the precision of predictive value estimates for risk markers.
  • This approach is particularly beneficial when marker accuracy is consistent across different populations.
  • The methodology offers improved risk prediction for diseases like prostate cancer.